The most accurate FDA cleared device to aid in the objective diagnosis of concussion
Using AI to provide immediate and baseline-free test results
Patented technology based on published research
- “These findings suggest that an objective eye tracking variable, like the BOX score, is effort independent and could be a useful addition to the current concussion battery, providing clinicians with an objective tool to identify visual impairments that are not currently being evaluated.”
- “The technology is rapid, noninvasive, automatable, portable and does not require literacy in any particular language. Its objectivity arises from the fact that it assesses relatively passive eye movements rather than requiring a subject to follow instructions and move their eyes deliberately.”
- “The BOX score was not significantly associated with symptoms, Standardized Assessment of Concussion, or computerized neuro- cognitive outcomes, all of which are frequently used concussion clinical assessments. In addition, there was no significant relationship between BOX score and the vision-based clinical variables (near point of convergence, binocular accommodative amplitude) measured in this investigation. This lack of overlap suggests that eye tracking may address a unique physiological domain not currently evaluated by other commonly used concussion assessments. Furthermore, eye tracking has successfully and reliably identified abnormal convergence and accommodation in a concussed adolescent population. Therefore, an objective eye tracking marker, such as BOX score, may be considered as a useful addition to a baseline multifaceted concussion examination.”
The EyeBOX is the most accurate objective test authorized by the FDA as an aid in the diagnosis of concussion.
Founded by neurosurgeon Uzma Samadani, M.D., Ph.D., Oculogica’s breakthrough technology transforms how concussions, also known as mild traumatic brain injuries (mTBI), are diagnosed. Watch her TedMed talk about the science behind the technology